Core for COVID-19 Cohort (IMPACC)

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3U19AI089992-09S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $1,087,629
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Pending
  • Research Location

    United States of America
  • Lead Research Institution

    YALE UNIVERSITY
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Subject

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

A core facility for the IMPACC study group will be formed to conduct analyses of samplescollected by the individual study sites. Shared protocols for subject enrollment and samplecollection have been established by the IMPACC study group. Collection and shipping to thecore site will be overseen by the Data Coordinating Center. Core assays will includemultiparameter single cell CyTOF of endotracheal aspirates and DNA sequencing. Corefunctions will be conducted in close collaboration with the IMPACC study group and includesample tracking and management, design of antibody labeling panel, sample processing andacquisition, DNA sequencing, initial data quality analysis and data sharing.